Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04684199 · ClinicalTrials.gov registry record · NA

Melatonin in Pediatric FD Population

A NA study of Dyspepsia, sponsored by Children's Mercy Hospital Kansas City.

Completed
Registry status
NA
Development phase
14
Enrollment target
1
Study location

NCT04684199 is a NA study of Dyspepsia that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 14 participants, below the 76-participant average among 11 other Dyspepsia trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04684199, a NA study of Dyspepsia, has completed, sponsored by Children's Mercy Hospital Kansas City.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

There are two specific aims in this study. Specific Aim 1: Determine if melatonin results in a higher grade of clinical response than does placebo in children with functional dyspepsia (FD). Hypothesis: treatment of FD with melatonin will result in a higher grade of clinical response than will treatment with a placebo. Specific Aim 2: Evaluate the relationship between changes in sleep and improvement in pain in pediatric patients with functional dyspepsia receiving melatonin. Hypothesis: There will be no association between improvement in pain and improvement in sleep in children with functional dyspepsia receiving melatonin.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Melatonin

Study Locations (1)

Missouri

  • Children's Mercy - Kansas City

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2014-08
Est. Completion 2015-04
Phase NA

What the Registry Record Tells You About NCT04684199

The ClinicalTrials.gov registry entry for NCT04684199 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 76-participant average among 11 other Dyspepsia trials with a reported enrollment target (82% lower). The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dyspepsia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT04684199 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT04684199 about?

NCT04684199 is a clinical study titled "Melatonin in Pediatric FD Population". There are two specific aims in this study. Specific Aim 1: Determine if melatonin results in a higher grade of clinical response than does placebo in children with functional dyspepsia (FD). Hypothesis: treatment of FD with melatonin will result in a higher grade of clinical response than will tre...

What is the current status of trial NCT04684199?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2014-08. Estimated completion is 2015-04.

What conditions does trial NCT04684199 study?

This clinical trial studies the following conditions: Dyspepsia.

What interventions are being tested in trial NCT04684199?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Melatonin (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04684199?

This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04684199 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dyspepsia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.